Real World Evidence (RWE) 201 – France – Health Data Hub: Facilitating Access to Real World Data
The purpose of France’s Health Data Hub (HDH) is to facilitate the sharing of health data to support research and innovation. Launched in December 2019, the HDH is a health data platform established by the French government to combine existing health databases and make them more accessible for research and development purposes [1].
The platform allows public interest project leaders to access large volumes of data and utilize the platform’s computing power to run complex research algorithms [2].
The reuse of health data has significant potential for enhancing healthcare quality and patient support through research. This includes [3]:
- Evaluating the effectiveness of treatments for rare pathologies like sarcoma by combining patient and insurance data.
- Enhancing prescription alert systems to help healthcare professionals make better decisions in complex clinical scenarios.
- Developing early warning tools for conditions like heart failure by correlating pacemaker and hospitalization data.
- Predicting disease progression, as in Parkinson’s disease, and improving preventive measures using patient cohort data.
- Streamlining the reporting and analysis of adverse drug reactions to improve healthcare system transparency.
- Utilizing AI to improve early cancer screening, thus reducing false positives and negatives, and saving medical time.
- Gathering data on long-term effects of medications, particularly in cases of organ transplantation, to optimize therapeutic strategies.
Researchers interested in accessing real-world data (RWD) and generating real-world evidence (RWE) can benefit from the HDH in several ways:
- Data Accessibility: The HDH provides a single gateway for health data in France, making it easier for researchers to access various data sources [4].
- Data Catalogue: The platform includes a data catalogue with one of the world’s largest healthcare claims databases, offering researchers a rich source of information for their studies [4].
- Collaboration: The HDH brings together 56 stakeholders, including the largest French public organization for scientific research, CNRS, fostering collaboration between government, producers of health data, and users of public and private health data [1].
- Support for Projects: The HDH provides researchers with the necessary resources and infrastructure to carry out their studies [4].
- Data Security: The platform ensures the protection of health data through a data access approval process, maintaining the privacy and security of sensitive information [4].
By providing researchers with easier access to health data and the necessary resources to analyse and process this data, the HDH can help generate valuable insights and contribute to advancements in the health sector [4].
References:
[1] Everything you need to know about Health Data Hub – Implicity
Link: https://www.implicity.com/everything-you-need-to-know-about-health-data-hub/
[2] The Health Data Hub publishes its roadmap for 2022 – French Healthcare (30 May 2022)
Link: https://frenchhealthcare.fr/the-health-data-hub-publishes-its-roadmap-for-2022/
[3] Health Data Hub – FAQ in English
Link: https://www.health-data-hub.fr/page/faq-english
[4] Health Data Hub – Multi-stakeholder workshop RWD quality and RWE use (26 June 2023)
Share this story...
Real World Evidence (RWE) 201…THE END – A Landscape Analysis of Regional RWE Frameworks – The European Health Data Space and DARWIN-EU
RWE 201 - THE END - A Landscape Analysis of Regional RWE Frameworks - The European Health Data Space and DARWIN-EU In our real world evidence (RWE) 201 series [...]
Real World Evidence (RWE) – Event Horizon
RWE 201 - RWE Event Horizon The term "event horizon" in the context of pharmaceuticals, particularly when discussing the shift towards real-world evidence (RWE) in regulatory submissions, is metaphorically [...]
Real World Evidence (RWE) 201 – Advancing Healthcare in Australia: Embracing Real-World Evidence and Data in Medicine Regulation and Development
RWE 201 - Advancing Healthcare in Australia: Embracing Real-World Evidence and Data in Medicine Regulation and Development Australia has several real-world evidence (RWE) initiatives to support healthcare [...]
Real World Evidence (RWE) 201 – South Korea’s Pioneering Approach: Integrating Real-World Evidence in Healthcare and Drug Development
RWE 201 - South Korea's Pioneering Approach: Integrating Real-World Evidence in Healthcare and Drug Development South Korea has several initiatives to support healthcare and drug development using [...]
Real World Evidence (RWE) 201 – Taiwan: Integrating Real-World Evidence for Drug Development and Policy Making
RWE 201 - Taiwan: Integrating Real-World Evidence for Drug Development and Policy Making Taiwan has several real-world evidence (RWE) initiatives to support healthcare and drug development. Over the past [...]
Real World Evidence (RWE) 201 – Revolutionizing Healthcare in Japan: The Rise of Real-World Evidence in Drug Development
RWE 201 - Revolutionizing Healthcare in Japan: The Rise of Real-World Evidence in Drug Development Japan has several initiatives to support healthcare and drug development using real-world evidence (RWE). [...]